Iqvia reports fourth-quarter and full-year 2024 results; reaffirms full-year 2025 guidance

Research triangle park, n.c.--(business wire)--iqvia holdings inc. (“iqvia”) (nyse:iqv), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended december 31, 2024. "iqvia delivered excellent fourth quarter performance, closing out a strong 2024," said ari bousbib, chairman and ceo of iqvia. "r&ds revenue was on target and bookings exceeded o.
IQV Ratings Summary
IQV Quant Ranking